1 results match your criteria: "Hartmann Radiotherapy and Radiosurgery Institute[Affiliation]"
Stereotactic ablative radiotherapy for unresectable inferior vena cava tumor thrombus in a patient with renal cell carcinoma: a case report.
Strahlenther Onkol
April 2023
Hartmann Radiotherapy and Radiosurgery Institute, 4 rue Kleber, 92200, Levallois Perret, Ile de France, France.
Purpose: Treatment options for renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) are limited and carry substantial risks. Currently, there are no standard treatment options in the setting of recurrent or unresectable RCC with IVC-TT.
Methods: We report our experience of treating an IVC-TT RCC patient with stereotactic body radiation therapy (SBRT).